Nestle baby food FSSAI case: what India’s legal action means for infant formulas

India’s Food Safety and Standards Authority of India (FSSAI) has launched legal action against Nestlé India’s baby food products.[1][2][5][11][15] The “Nestle baby food FSSAI case” concerns NAN Excella Pro, Lactogen Pro, and a follow-up formula, raising questions over nutrient levels and promotional claims.

Nestle baby food FSSAI case: what exactly happened?

Between 18–19 September 2026, the Food Safety and Standards Authority of India (FSSAI) disclosed it had filed three adjudication cases against Nestlé India over its infant nutrition products.[1][2][5][11][15] The core issues are:

* Substandard Biotin: A sample of a Nestlé follow‑up formula was found to have biotin (vitamin B7) levels below the legal minimum required by the Food Safety and Standards (Foods for Infant Nutrition) Regulations, 2020.[1][10][11][15] A re‑analysis at a referral laboratory confirmed the sample was non‑conforming.[10][15] The finding applies to one tested sample, not all batches.

* Questionable Promotional Claims: FSSAI is scrutinizing claims on two products, alleging they violate Regulation 4(2) of the 2020 infant nutrition rules.[14][15]

* NAN Excella Pro Stage 1: Claims related to “5 HMOs” and “Whey Protein” on e‑commerce platforms are under review.[2][3][11][14][15]

* Lactogen Pro 1: The claim that its whey protein is “easy to digest” is also being questioned.[3][11][14][15]

* Legal Action: The three adjudication cases (two for claims, one for biotin) are a civil regulatory process that can result in monetary penalties and corrective orders.[2][11][14]

* Nestlé’s Position: Nestlé India stated it is “fully compliant” with regulations and is cooperating.[7] No official recall has been issued by FSSAI for these products.

FSSAI rules for infant nutrition products: why this matters beyond Nestlé

This case highlights key FSSAI rules for infant nutrition products that apply to all brands.

• Strict Nutrient Standards: The Food Safety and Standards (Foods for Infant Nutrition) Regulations, 2020 set minimum and maximum levels for nutrients like biotin. Any sample below the minimum can be deemed “sub-standard.”[15]
• Control of Health Claims: Regulation 4(2) restricts promotions that suggest superiority to breast milk or make unsubstantiated claims about digestibility, special proteins, or HMOs.[15]
• Monitoring of Online Promotions: FSSAI examined e‑commerce listings and digital marketing, signaling that online product pages and ads are under regulatory scrutiny.[14][15]
• Adjudication Process: FSSAI files adjudication cases to seek financial penalties, orders to change labels or claims, and other corrective actions under the civil regulatory framework.[11][14]

What this means for parents: Is Nestle baby food safe in India?

The FSSAI findings concern regulatory compliance, not a declared widespread safety emergency.

* There is no public recall order for NAN Excella Pro 1, Lactogen Pro 1, or the follow‑up formula.[1][6][8] The action targets non‑compliance in one tested sample and promotional claims.[1][10][11][15]

* Biotin is critical for metabolism, but a deficiency typically develops over time. The finding in a single sample raises questions about quality control.

* All infant formulas sold in India must comply with the 2020 infant nutrition regulations.[15] This case signals FSSAI is actively enforcing these rules across the category.

* Marketing claims like “easy to digest,” “5 HMOs,” or “pro” proteins should not be the primary basis for choosing a formula. Prioritize age-appropriateness and medical advice.

* Following the news, Nestlé India’s share price fell around 2–3% on 18 September, reflecting investor concern over regulatory scrutiny and brand trust.[2][6][13]

* Parents using these formulas should consult a paediatrician about nutrient sufficiency and alternatives. Decisions should be based on a baby’s health and medical advice.

What parents should do now: a practical checklist

• Check the Product: Note the full product name (NAN Excella Pro Stage 1, Lactogen Pro 1, etc.) and batch number/manufacturing date from your pack in case of future targeted advisories.
• Consult Your Paediatrician Before Acting: Do not switch formulas abruptly, as this can cause digestive upset. Discuss any concerns about NAN Excella Pro, Lactogen Pro, or other formulas with your paediatrician. Base any changes on their medical advice for your child.
• Treat Claims as Marketing: Until the case is resolved, view terms like “pro”, “HMO”, and “easy to digest” as marketing language, not a guarantee of superior benefit.
• Use Official Sources: Follow FSSAI’s official website and verified channels for updates, not social media forwards.[10][12]
• Report Quality Issues: If you notice an unusual smell, texture, or packaging defect, stop using the pack. Report the issue to local food safety authorities or FSSAI with the batch number and purchase details.

Frequently Asked Questions

Keep reading